The Salmonella T3SS1 effector IpaJ is regulated by ItrA and inhibits the MAPK signaling pathway
Chao Yin,Jiaojie Gu,Dan Gu,Zhenyu Wang,Ruoyun Ji,Xinan Jiao,Qiuchun Li
DOI: https://doi.org/10.1371/journal.ppat.1011005
IF: 7.464
2022-12-09
PLoS Pathogens
Abstract:Invasion plasmid antigen J (IpaJ) is a protein with cysteine protease activity that is present in Salmonella and Shigella species. Salmonella enterica serovar Pullorum uses IpaJ to inhibit the NF-κB pathway and the subsequent inflammatory response, resulting in bacterial survival in host macrophages. In the present study, we performed a DNA pull-down assay and EMSA and identified ItrA, a new DeoR family transcriptional regulator that could control the expression of IpaJ by directly binding to the promoter of ipaJ . The deletion of itrA inhibited the transcription of ipaJ in Salmonella . Tn-Seq revealed that two regulators of Salmonella pathogenicity island 1 (SPI-1), namely HilA and HilD, regulated the secretion of IpaJ. The deletion of hilA , hilD or SPI-1 inhibited the secretion of IpaJ in both cultured medium and Salmonella -infected cells. In contrast, the strain with the deletion of ssrB (an SPI-2 regulator-encoding gene) displayed normal IpaJ secretion, indicating that IpaJ is an effector of the SPI-1-encoded type III secretion system (T3SS1). To further demonstrate the role of IpaJ in host cells, we performed quantitative phosphoproteomics and compared the fold changes in signaling molecules in HeLa cells infected with wild-type S . Pullorum C79-13 with those in HeLa cells infected with the ipaJ -deleted strain C79-13ΔpSPI12. Both phosphoproteomics and Western blot analyses revealed that p-MEK and p-ERK molecules were increased in C79-13ΔpSPI12- and C79-13ΔpSPI12-p ipaJ (C45A)-infected cells; and Co-IP assays demonstrated that IpaJ interacts with Ras to reduce its ubiquitination, indicating that IpaJ can inhibit the activation of the MAPK signaling pathway. As a cysteine protease, IpaJ present in both Salmonella and Shigella is delivered into host cells to display its activity. However, the expression and secretion of IpaJ remains unclear. Here, we identified a novel DeoR family transcriptional regulator ItrA controlling the transcription of ipaJ , and demonstrated that the expressed IpaJ is an effector of T3SS1. IpaJ can be secreted into culture supernatant in vitro and host cell in vivo dependent on T3SS1. After injection into host cells, IpaJ can not only inhibit the NF-κB pathway and the subsequent inflammatory response through by suppressing IκBα ubiquitination, but also inhibit the activation of the MAPK signaling pathway through downregulation of p-MEK and p-ERK molecules. In summary, we revealed the molecular mechanism of IpaJ expression and secretion in Salmonella , and demonstrated its role in inhibiting host MAPK signaling pathway.
microbiology,virology,parasitology